Literature DB >> 21651393

Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance.

Agnès Linglart1, Christine Menguy, Alain Couvineau, Colette Auzan, Yasemin Gunes, Mathilde Cancel, Emmanuelle Motte, Graziella Pinto, Philippe Chanson, Pierre Bougnères, Eric Clauser, Caroline Silve.   

Abstract

The skeletal dysplasia characteristic of acrodysostosis resembles the Albright's hereditary osteodystrophy seen in patients with pseudohypoparathyroidism type 1a, but defects in the α-stimulatory subunit of the G-protein (GNAS), the cause of pseudohypoparathyroidism type 1a, are not present in patients with acrodysostosis. We report a germ-line mutation in the gene encoding PRKAR1A, the cyclic AMP (cAMP)-dependent regulatory subunit of protein kinase A, in three unrelated patients with acrodysostosis and resistance to multiple hormones. The mutated subunit impairs the protein kinase A response to stimulation by cAMP; this explains our patients' hormone resistance and the similarities of their skeletal abnormalities with those observed in patients with pseudohypoparathyroidism type 1a.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21651393     DOI: 10.1056/NEJMoa1012717

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  56 in total

Review 1.  Advances in Skeletal Dysplasia Genetics.

Authors:  Krista A Geister; Sally A Camper
Journal:  Annu Rev Genomics Hum Genet       Date:  2015-04-22       Impact factor: 8.929

2.  Two PKA RIα holoenzyme states define ATP as an isoform-specific orthosteric inhibitor that competes with the allosteric activator, cAMP.

Authors:  Tsan-Wen Lu; Jian Wu; Phillip C Aoto; Jui-Hung Weng; Lalima G Ahuja; Nicholas Sun; Cecilia Y Cheng; Ping Zhang; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-30       Impact factor: 11.205

3.  cAMP-dependent activation of the Rac guanine exchange factor P-REX1 by type I protein kinase A (PKA) regulatory subunits.

Authors:  Sendi Rafael Adame-García; Rodolfo Daniel Cervantes-Villagrana; Lennis Beatriz Orduña-Castillo; Jason C Del Rio; J Silvio Gutkind; Guadalupe Reyes-Cruz; Susan S Taylor; José Vázquez-Prado
Journal:  J Biol Chem       Date:  2018-12-10       Impact factor: 5.157

4.  Inactivation of the Carney complex gene 1 (PRKAR1A) alters spatiotemporal regulation of cAMP and cAMP-dependent protein kinase: a study using genetically encoded FRET-based reporters.

Authors:  Laure Cazabat; Bruno Ragazzon; Audrey Varin; Marie Potier-Cartereau; Christophe Vandier; Delphine Vezzosi; Marthe Risk-Rabin; Aziz Guellich; Julia Schittl; Patrick Lechêne; Wito Richter; Viacheslav O Nikolaev; Jin Zhang; Jérôme Bertherat; Grégoire Vandecasteele
Journal:  Hum Mol Genet       Date:  2013-10-10       Impact factor: 6.150

5.  Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutations.

Authors:  Ola Nilsson; Michael H Guo; Nancy Dunbar; Jadranka Popovic; Daniel Flynn; Christina Jacobsen; Julian C Lui; Joel N Hirschhorn; Jeffrey Baron; Andrew Dauber
Journal:  J Clin Endocrinol Metab       Date:  2014-04-24       Impact factor: 5.958

Review 6.  Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.

Authors:  Giovanna Mantovani; Anna Spada; Francesca Marta Elli
Journal:  Nat Rev Endocrinol       Date:  2016-04-22       Impact factor: 43.330

Review 7.  Genetics of Short Stature.

Authors:  Youn Hee Jee; Anenisia C Andrade; Jeffrey Baron; Ola Nilsson
Journal:  Endocrinol Metab Clin North Am       Date:  2017-02-23       Impact factor: 4.741

8.  A Heterozygous Splice-Site Mutation in PTHLH Causes Autosomal Dominant Shortening of Metacarpals and Metatarsals.

Authors:  Monica Reyes; Bert Bravenboer; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2019-01-02       Impact factor: 6.741

Review 9.  cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.

Authors:  Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-02-26       Impact factor: 4.102

Review 10.  An update on the clinical and molecular characteristics of pseudohypoparathyroidism.

Authors:  Michael A Levine
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-12       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.